Nicholas Corsi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicholas Corsi has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- David-Dan Nguyen
Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
2 shared publications - Matthew P. Corsi
Wayne State University School of Medicine, Detroit, MI, USA
2 shared publications - Adel Arezki
Division of Urology, McGill University, Montreal, Canada
1 shared publication - Ahmad A. Abu-Heija
Internal Medicine, Wayne State University, Detroit Medical Center, Detroit, USA
1 shared publication Anand Kumar Ravi
Wayne State University School of Medicine, Detroit, MI, USA
1 shared publicationAnton Wintner
Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
1 shared publication
Latest Publications
- Open Access
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Ureteroscopic Aspiration Dynamics and Stone Fragment Evacuation: In Vitro Comparison of the Second-Generation CVAC System and Direct In-Scope Suction
Objective: To compare the aspiration efficiency and fragment evacuation performance of the second-generation CVAC aspiration system with direct in-scope suction (DISS) devices.Methods: Synthetic stones (Begostone) were sieved into five size groups (63 µm–3.3 mm). The CVAC catheter (7 Fr lumen) was tested against two DISS ureteroscopes (Pusen 3.6 Fr and 5.1 Fr). Standardized trials were performed using a Thermedx irrigation system (160 mmHg) and Neptune suction (155 mmHg). Endpoints included aspiration efficiency (g/min), clearance success within 180 s, time to clearance (Kaplan–Meier analysis), and clogging incidence.Results: CVAC achieved significantly higher aspiration efficiency than DISS across all fragment sizes (p < 0.01), with rates up to 41× greater (Group 4 vs. Pusen 3.6 Fr). Complete clearance within 180 s was achieved in 100% of CVAC trials for Groups 1–4 and in 25% of Group 5 runs, whereas both Pusen devices failed consistently in Groups 3–5. Kaplan–Meier analysis confirmed faster and more complete clearance with CVAC (median 49 s, 95% CI: 44–90 s), while neither Pusen device reached median clearance. Cox modeling showed the probability of clearance with Pusen devices was <25% that of CVAC. Only CVAC maintained partial or complete clearance when clogs occurred.Conclusions: The CVAC system outperformed DISS in aspiration efficiency, clearance rates, and time to clearance across multiple fragment sizes. These findings highlight the advantages of a dual-channel simultaneous irrigation–aspiration design compared to DISS systems. Further ex vivo and clinical studies are warranted to confirm these results in vivo.
- 10 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessUreteroscopic Aspiration Dynamics and Stone Fragment Evacuation: In Vitro Comparison of the Second-Generation CVAC System and Direct In-Scope Suction
Objective: To compare the aspiration efficiency and fragment evacuation performance of the second-generation CVAC aspiration system with direct in-scope suction (DISS) devices.Methods: Synthetic stones (Begostone) were sieved into five size groups (63 µm–3.3 mm). The CVAC catheter (7 Fr lumen) was tested against two DISS ureteroscopes (Pusen 3.6 Fr and 5.1 Fr). Standardized trials were performed using a Thermedx irrigation system (160 mmHg) and Neptune suction (155 mmHg). Endpoints included aspiration efficiency (g/min), clearance success within 180 s, time to clearance (Kaplan–Meier analysis), and clogging incidence.Results: CVAC achieved significantly higher aspiration efficiency than DISS across all fragment sizes (p < 0.01), with rates up to 41× greater (Group 4 vs. Pusen 3.6 Fr). Complete clearance within 180 s was achieved in 100% of CVAC trials for Groups 1–4 and in 25% of Group 5 runs, whereas both Pusen devices failed consistently in Groups 3–5. Kaplan–Meier analysis confirmed faster and more complete clearance with CVAC (median 49 s, 95% CI: 44–90 s), while neither Pusen device reached median clearance. Cox modeling showed the probability of clearance with Pusen devices was <25% that of CVAC. Only CVAC maintained partial or complete clearance when clogs occurred.Conclusions: The CVAC system outperformed DISS in aspiration efficiency, clearance rates, and time to clearance across multiple fragment sizes. These findings highlight the advantages of a dual-channel simultaneous irrigation–aspiration design compared to DISS systems. Further ex vivo and clinical studies are warranted to confirm these results in vivo.
- Open Access
- 1 February 2024
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 2 (2)
Trends in PubMed-Indexed Research in Matched Urology Applicants: A Cross-Sectional Analysis of the 2017 to 2021 Match Cycles
Purpose: Urology is one of the most competitive specialties for residency matches in the United States. Data reported by the American Urological Association from match cycles spanning 2014 to 2021 reveal a median of 0.34% (0%-3%) of unfilled spots, a median of 1.48 (1.28-1.87) applicants per position, and a median of 75% (63%-87%) match rate. Recent research has shown that program directors value applicants' research highly. We sought to assess the research productivity of matched urology residency applicants, identify trends in research volume over time, and investigate the potential correlation between research output and program ranking. Materials and Methods: Doximity Urology program ranking list from the 2017 to 2021 match cycles was sorted by reputation, extracted, and populated using each program's official website resident roster, including name, medical school, postgraduate year, and additional degrees. Rosters were crossed-checked against social media posts from the official accounts. Each identified urology resident was queried in PubMed. Journal ranking was determined through Scimagojr; top-quartile journals were classified as Q1. Results: In total 131 of 145 programs were identified, and 1605 matched applicants spanning the 2017 to 2021 match cycles. The mean and median total publications were 2.44 and 1, respectively, and 2.17 and 1 when excluding case reports. 64.2% of applicants had at least one publication, and 42.2% had at least one urological publication. Applicants matching into higher-ranked programs had more research and urological research. Multivariable regression analysis revealed that Q1 research (β 2.38) and urology research (β 2.33) significantly affected rank. Match cycle analysis revealed an increase in total and urology-focused research, whereas regression analysis demonstrated significant increases in total publications (β 0.019) per cycle. Conclusion: Overall research, urology-focused research, first authorship, and publication in higher-ranked journals play an essential role in the urology match.
- 1 February 2024
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 2 (2)
Open AccessTrends in PubMed-Indexed Research in Matched Urology Applicants: A Cross-Sectional Analysis of the 2017 to 2021 Match Cycles
Purpose: Urology is one of the most competitive specialties for residency matches in the United States. Data reported by the American Urological Association from match cycles spanning 2014 to 2021 reveal a median of 0.34% (0%-3%) of unfilled spots, a median of 1.48 (1.28-1.87) applicants per position, and a median of 75% (63%-87%) match rate. Recent research has shown that program directors value applicants' research highly. We sought to assess the research productivity of matched urology residency applicants, identify trends in research volume over time, and investigate the potential correlation between research output and program ranking. Materials and Methods: Doximity Urology program ranking list from the 2017 to 2021 match cycles was sorted by reputation, extracted, and populated using each program's official website resident roster, including name, medical school, postgraduate year, and additional degrees. Rosters were crossed-checked against social media posts from the official accounts. Each identified urology resident was queried in PubMed. Journal ranking was determined through Scimagojr; top-quartile journals were classified as Q1. Results: In total 131 of 145 programs were identified, and 1605 matched applicants spanning the 2017 to 2021 match cycles. The mean and median total publications were 2.44 and 1, respectively, and 2.17 and 1 when excluding case reports. 64.2% of applicants had at least one publication, and 42.2% had at least one urological publication. Applicants matching into higher-ranked programs had more research and urological research. Multivariable regression analysis revealed that Q1 research (β 2.38) and urology research (β 2.33) significantly affected rank. Match cycle analysis revealed an increase in total and urology-focused research, whereas regression analysis demonstrated significant increases in total publications (β 0.019) per cycle. Conclusion: Overall research, urology-focused research, first authorship, and publication in higher-ranked journals play an essential role in the urology match.
- 19 December 2022
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (2) , 529-536
Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database
Introduction GreenLight photoselective vaporization of the prostate (PVP) has gained widespread adoption as an option to traditional transurethral resection of the prostate. Prior reports expressed concern with the use of PVP in large prostates. The aim of this study was to investigate the adjusted outcomes of GreenLight PVP in men with large (≥ 80 cc) vs. small prostates (< 80 cc). Methods Data were obtained from the Global Greenlight Group which pools data from 7 high volume centers. Men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible and assigned into two groups based on their prostate size (≥ 80 and < 80 cc). 11 functional and perioperative covariates were collected. Analyses were adjusted for patient age and presence of median lobe. Results 3426 men met the inclusion criteria. 34.6% (n = 1187) of patients had a large prostate size. Baseline age and prostate volume were significantly different between the groups. The magnitude of absolute improvement in unadjusted international prostate symptom score was significantly greater in the large (≥ 80 cc) prostate group at 12 months, with an absolute change of 19.17 points (95% CI 18.46–19.88; p < 0.01). There was also a significant drop in PVR at both 6- (p = 0.007) and 12 months (p = 0.005). There were no significant differences in transfusion (p = 0.42), hematuria (p = 0.80), or 30-day readmission rates (p = 0.28). Conclusions Greenlight PVP is a safe and effective alternative for patients with prostate sizes ≥ 80 cc, with durable outcomes relatively independent from prostate size.
- 19 December 2022
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (2) , 529-536
Functional outcomes of GreenLight 180-W photoselective vaporization in patients with large (≥ 80 cc) prostates: an analysis of over 3000 men in the Global Greenlight Group (GGG) database
Introduction GreenLight photoselective vaporization of the prostate (PVP) has gained widespread adoption as an option to traditional transurethral resection of the prostate. Prior reports expressed concern with the use of PVP in large prostates. The aim of this study was to investigate the adjusted outcomes of GreenLight PVP in men with large (≥ 80 cc) vs. small prostates (< 80 cc). Methods Data were obtained from the Global Greenlight Group which pools data from 7 high volume centers. Men with established benign prostatic hyperplasia who underwent GreenLight PVP using the XPS-180 W system between 2011 and 2019 were eligible and assigned into two groups based on their prostate size (≥ 80 and < 80 cc). 11 functional and perioperative covariates were collected. Analyses were adjusted for patient age and presence of median lobe. Results 3426 men met the inclusion criteria. 34.6% (n = 1187) of patients had a large prostate size. Baseline age and prostate volume were significantly different between the groups. The magnitude of absolute improvement in unadjusted international prostate symptom score was significantly greater in the large (≥ 80 cc) prostate group at 12 months, with an absolute change of 19.17 points (95% CI 18.46–19.88; p < 0.01). There was also a significant drop in PVR at both 6- (p = 0.007) and 12 months (p = 0.005). There were no significant differences in transfusion (p = 0.42), hematuria (p = 0.80), or 30-day readmission rates (p = 0.28). Conclusions Greenlight PVP is a safe and effective alternative for patients with prostate sizes ≥ 80 cc, with durable outcomes relatively independent from prostate size.
- 6 October 2022
- Published by Elsevier in European Urology Focus
- Vol. 9 (2) , 396-402
Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact?
- 6 October 2022
- Published by Elsevier in European Urology Focus
- Vol. 9 (2) , 396-402
Top 100 Urology Influencers on Twitter: Is Social Media Influence Associated with Academic Impact?
- Open Access
- 22 July 2022
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2022, 1-4
Wilkie’s Syndrome following Chemotherapy: A Case Report and a Review of Literature
Superior mesenteric artery (SMA) syndrome is a rare etiology of upper gastrointestinal obstruction. The measured angle between the SMA and the aorta is typically between 38 and 65° and maintained by mesenteric fat. Excessive fat loss can lead to intestinal obstruction due to an exaggerated acute angularity of the SMA, compressing the third part of the duodenum. We present a 22-year-old female with a history of aplastic anemia, status post bone-marrow transplant, who presented with intractable nausea and had confirmed SMA syndrome on CT angiography. Subsequently, the patient underwent nasogastric decompression and successful laparoscopic duodenojejunostomy.
- 22 July 2022
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2022, 1-4
Open AccessWilkie’s Syndrome following Chemotherapy: A Case Report and a Review of Literature
Superior mesenteric artery (SMA) syndrome is a rare etiology of upper gastrointestinal obstruction. The measured angle between the SMA and the aorta is typically between 38 and 65° and maintained by mesenteric fat. Excessive fat loss can lead to intestinal obstruction due to an exaggerated acute angularity of the SMA, compressing the third part of the duodenum. We present a 22-year-old female with a history of aplastic anemia, status post bone-marrow transplant, who presented with intractable nausea and had confirmed SMA syndrome on CT angiography. Subsequently, the patient underwent nasogastric decompression and successful laparoscopic duodenojejunostomy.